MedPath

Ovarian Histopathology and Laparoscopic Assessment of Premature Ovarian Failure

Not Applicable
Conditions
Premature Ovarian Failure
Interventions
Procedure: laparoscopy
Registration Number
NCT03412487
Lead Sponsor
Cairo University
Brief Summary

25 women with Premature Ovarian Failure who attended Fayoum university hospital gynecology outpatient clinic (case group) and another group of 25 women with normal ovarian function (control group).

\*Pelvic laparoscopy and ovarian biopsy will be done ovarian biopsy preparation

For assessment of autoimmune oophoritis, sections were immunostained with anti-LCA (CD45) monoclonal antibody

Detailed Description

25 women with Premature Ovarian Failure who attended Fayoum university hospital gynecology outpatient clinic (case group) and another group of 25 women with normal ovarian function (control group).Pelvic laparoscopy and ovarian biopsy To be examined histologically. All procedures were performed under general anesthesia the utero-ovarian ligament was stabilized with the round biopter introduced through the other. The round metal biopter 5 mm in diameter with an inner protective trocar.

The tip of the biopsy instrument was placed on an area of the ovary free of cysts; the hilar area was avoided because it is deficient in small follicles. After correct placement was verified, the inner protecting trocar was removed to expose the sharp leading edge of the round sheath. Gentle circular movements were made cutting through the ovarian cortex to produce a 5-mm disk of 2-3 mm in thickness. The round biopter was removed, and a grasper was introduced to recover the excised tissue.

Ovarian biopsy specimens were fixed in 10% formalin and embedded in paraffin forming tissue blocks. Two sections, 4μ thick were cut from each block. One was stained with routine haematoxylin and eosin (H\&E) stain while the other was immunostained with anti-Leukocyte Common Antigen (LCA).

For assessment of autoimmune oophoritis, sections were immunostained with anti-LCA (CD45) monoclonal antibody

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Woman under age of 40y.

    • Infertility.
    • History of oligomenorrhea or amenorrhea for 1 year or more FSH level >20 IU/L at least 2 occasions 4-6 weeks apart (FSH level 20-40 IU/L indicates ovarian insufficiency, while level above 40 IU/L indicates complete failure).
    • History of thyroid dysfunction, postpartum thyroiditis and or thyroid surgery.
    • Symptoms or signs suggestive of thyroid dysfunction or goiter.
    • Family history of thyroid dysfunction or goiter.
    • Presence of thyroid antibodies or other antibodies.
    • Type 1 Diabetes Mellitus.
    • Prior irradiation to head and neck
Read More
Exclusion Criteria
  • Women above 40 yrs.

    • Follicle stimulating hormone (FSH) less than 20mIU/mL
    • Women using hormonal treatement, exposed to radiation to abdomen or pelvis, chemotherapy, or ovarian surgery.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control grouplaparoscopyA group of female patients presented with infertility but with regular menses and normal ovarian function (according to history, general examination, gynecological examination and FSH level).
premature ovarian failurelaparoscopywomen under 40 years old with History of oligomenorrhea or amenorrhea for 1 year or more FSH level \>20 IU/L at least 2 occasions 4-6 weeks apart (FSH level 20-40 IU/L indicates ovarian insufficiency, while level above 40 IU/L indicates complete failure).
Primary Outcome Measures
NameTimeMethod
presence of autoimuune oophoritisat time of laproscopy procedure

Autoimmune oophritis was assessed by quantifying LCA positive cells in ovarian stroma as follows:

\[Type text\] 0= not convincing.

1. mild autoimmune oophritis.

2. moderate autoimmune oophritis.

3. sever autoimmune oophritis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr Alainy medical school

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath